Mechanism of methylated-histone inhibitor valemetostat (IMAGE)

University of Tokyo

Mechanism of methylated-histone inhibitor valemetostat

Caption

Researchers revealed the mechanism of the cancer drug valemetostat and established its efficacy in treating adult T-cell leukemia/lymphoma (ATL).

Credit

2024 Makoto Yamagishi, The University of Tokyo

Usage Restrictions

News organizations may use or redistribute this image, with proper attribution, as part of news coverage of this paper only.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.